{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,22]],"date-time":"2026-08-22T05:27:33Z","timestamp":1787376453216,"version":"build-2736575974"},"reference-count":51,"publisher":"Japanese Society for Magnetic Resonance in Medicine","issue":"4","funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["JP23K27556"],"award-info":[{"award-number":["JP23K27556"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["JP23K14903"],"award-info":[{"award-number":["JP23K14903"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["JP20K08035"],"award-info":[{"award-number":["JP20K08035"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["JP23K07189"],"award-info":[{"award-number":["JP23K07189"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"name":"JSPS Overseas Research Fellowship"},{"name":"Japanese Society of Neuroradiology"},{"name":"JST FOREST Program","award":["JPMJFR231P"],"award-info":[{"award-number":["JPMJFR231P"]}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["JP24wm0625310"],"award-info":[{"award-number":["JP24wm0625310"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100016289","name":"Taiju Life Social Welfare Foundation","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100016289","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["MRMS","magn reson med sci"],"published-print":{"date-parts":[[2026]]},"DOI":"10.2463\/mrms.mp.2026-0112","type":"journal-article","created":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T22:12:11Z","timestamp":1787263931000},"page":"n\/a","source":"Crossref","is-referenced-by-count":0,"title":["Brain Amyloid Burden Mapping Using MR Fingerprinting Aided by Deep Learning"],"prefix":"10.2463","volume":"25","author":[{"given":"Shohei","family":"Fujita","sequence":"first","affiliation":[{"name":"Department of Radiology, Juntendo University, Tokyo, Japan"},{"name":"Department of Radiology, The University of Tokyo, Tokyo, Japan"},{"name":"Athinoula A. Martinos Center for Biomedical Imaging, Massachusetts General Hospital, Boston MA, USA"},{"name":"Department of Radiology, Harvard Medical School, Boston MA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasutaka","family":"Fushimi","sequence":"additional","affiliation":[{"name":"Department of Diagnostic Imaging and Nuclear Medicine, Graduate School of Medicine, Kyoto University, Kyoto, Kyoto, Japan"},{"name":"Biomedical Imaging Research Center, University of Fukui, Eiheiji, Fukui, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yujiro","family":"Otsuka","sequence":"additional","affiliation":[{"name":"Department of Radiology, Juntendo University, Tokyo, Japan"},{"name":"Milliman Inc., Tokyo, Japan"},{"name":"Plusman LLC, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katsutoshi","family":"Murata","sequence":"additional","affiliation":[{"name":"Siemens Healthcare K.K., Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guido","family":"Buonincontri","sequence":"additional","affiliation":[{"name":"Research & Clinical Translation, Magnetic Resonance, Siemens Healthineers, Erlangen Bavaria, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregor","family":"Koerzdoerfer","sequence":"additional","affiliation":[{"name":"Siemens Medical Solutions, New York NY, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mathias","family":"Nittka","sequence":"additional","affiliation":[{"name":"Research & Clinical Translation, Magnetic Resonance, Siemens Healthineers, Erlangen Bavaria, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Issei","family":"Fukunaga","sequence":"additional","affiliation":[{"name":"Department of Radiology, Juntendo University, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaito","family":"Takabayashi","sequence":"additional","affiliation":[{"name":"Department of Radiology, Juntendo University, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akifumi","family":"Hagiwara","sequence":"additional","affiliation":[{"name":"Department of Radiology, Juntendo University, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yumiko","family":"Motoi","sequence":"additional","affiliation":[{"name":"Department of Neurology, Juntendo University, Tokyo, Japan"},{"name":"The Medical Center for Dementia, Juntendo University, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madoka","family":"Nakajima","sequence":"additional","affiliation":[{"name":"The Medical Center for Dementia, Juntendo University, Tokyo, Japan"},{"name":"Department of Neurosurgery, Juntendo University, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koji","family":"Murakami","sequence":"additional","affiliation":[{"name":"Division of Nuclear Medicine, Department of Radiology, Juntendo University, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atsushi","family":"Shima","sequence":"additional","affiliation":[{"name":"Department of Human Health Sciences, Graduate School of Medicine, Kyoto University, Kyoto, Kyoto, Japan"},{"name":"Department of Neurology, Kyoto University Graduate School of Medicine, Kyoto, Kyoto, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manabu","family":"Kubota","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, Graduate School of Medicine, Kyoto University, Kyoto, Kyoto, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Berkin","family":"Bilgic","sequence":"additional","affiliation":[{"name":"Athinoula A. Martinos Center for Biomedical Imaging, Massachusetts General Hospital, Boston MA, USA"},{"name":"Department of Radiology, Harvard Medical School, Boston MA, USA"},{"name":"Harvard\/MIT Health Sciences and Technology, Cambridge MA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koji","family":"Kamagata","sequence":"additional","affiliation":[{"name":"Department of Radiology, Juntendo University, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nobukatsu","family":"Sawamoto","sequence":"additional","affiliation":[{"name":"Department of Human Health Sciences, Graduate School of Medicine, Kyoto University, Kyoto, Kyoto, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Osamu","family":"Abe","sequence":"additional","affiliation":[{"name":"Department of Radiology, The University of Tokyo, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuji","family":"Nakamoto","sequence":"additional","affiliation":[{"name":"Department of Diagnostic Imaging and Nuclear Medicine, Graduate School of Medicine, Kyoto University, Kyoto, Kyoto, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shigeki","family":"Aoki","sequence":"additional","affiliation":[{"name":"Department of Radiology, Juntendo University, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1295","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Wimo A, Seeher K, Cataldi R, et al. The worldwide costs of dementia in 2019. Alzheimers Dement 2023; 19:2865\u20132873.","DOI":"10.1002\/alz.12901"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. 2023 Alzheimer\u2019s disease facts and figures. Alzheimers Dement 2023; 19:1598\u20131695.","DOI":"10.1002\/alz.13016"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Wong W. Economic burden of Alzheimer disease and managed care considerations. Am J Manag Care 2020; 26:S177\u2013S183.","DOI":"10.37765\/ajmc.2020.88482"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Chetelat G, Villemagne V, Bourgeat P, et al. IC\u2010P\u2010114: Relationship between atrophy and beta\u2010amyloid deposition in normal elderly, mild cognitive impairment and Alzheimer\u2019s disease. Alzheimers Dement 2010; 6:S45-S46.","DOI":"10.1016\/j.jalz.2010.05.129"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Sperling RA, Karlawish J, Johnson KA. Preclinical Alzheimer disease\u2014the challenges ahead. Nat Rev Neurol 2013; 9:54\u201358.","DOI":"10.1038\/nrneurol.2012.241"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Jack CR Jr., Knopman DS, Jagust WJ, et al. Hypothetical model of dynamic biomarkers of the Alzheimer\u2019s pathological cascade. Lancet Neurol 2010; 9:119\u2013128.","DOI":"10.1016\/S1474-4422(09)70299-6"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Hampel H, Hardy J, Blennow K, et al. The amyloid-\u03b2 pathway in Alzheimer\u2019s disease. Mol Psychiatry 2021; 26:5481\u20135503.","DOI":"10.1038\/s41380-021-01249-0"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Chen GF, Xu TH, Yan Y, et al. Amyloid beta: structure, biology and structure-based therapeutic development. Acta Pharmacol Sin 2017; 38:1205\u20131235.","DOI":"10.1038\/aps.2017.28"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Mantzavinos V, Alexiou A. Biomarkers for Alzheimer\u2019s disease diagnosis. Curr Alzheimer Res 2017; 14:1149\u20131154.","DOI":"10.2174\/1567205014666170203125942"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Meyer PF, McSweeney M, Gonneaud J, Villeneuve S. AD molecular: PET amyloid imaging across the Alzheimer\u2019s disease spectrum: From disease mechanisms to prevention. Prog Mol Biol Transl Sci 2019; 165:63\u2013106.","DOI":"10.1016\/bs.pmbts.2019.05.001"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Small GW, Kepe V, Ercoli LM, et al. PET of brain amyloid and tau in mild cognitive impairment. N Engl J Med 2006; 355:2652\u20132663.","DOI":"10.1056\/NEJMoa054625"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. McKhann GM, Knopman DS, Chertkow H, et al. The diagnosis of dementia due to Alzheimer\u2019s disease: Recommendations from the National Institute on Aging-Alzheimer\u2019s Association workgroups on diagnostic guidelines for Alzheimer\u2019s disease. Alzheimers Dement 2011; 7:263\u2013269.","DOI":"10.1016\/j.jalz.2011.03.005"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Frisoni GB, Boccardi M, Barkhof F, et al. Strategic roadmap for an early diagnosis of Alzheimer\u2019s disease based on biomarkers. Lancet Neurol 2017; 16:661\u2013676.","DOI":"10.1016\/S1474-4422(17)30159-X"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Tosun D, Veitch D, Aisen P, et al. Detection of \u03b2-amyloid positivity in Alzheimer\u2019s Disease Neuroimaging Initiative participants with demographics, cognition, MRI and plasma biomarkers. Brain Commun 2021; 3:fcab008.","DOI":"10.1093\/braincomms\/fcab008"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Gobbi LC, Knust H, K\u00f6rner M, et al. Identification of three novel radiotracers for imaging aggregated tau in Alzheimer\u2019s disease with positron emission tomography. J Med Chem 2017; 60:7350\u20137370.","DOI":"10.1021\/acs.jmedchem.7b00632"},{"key":"16","unstructured":"16. Radiation protection of patients during PET\/CT scanning. https:\/\/www.iaea.org\/resources\/rpop\/health-professionals\/nuclear-medicine\/pet-ct\/patients (Published July 27, 2017. Accessed December 23, 2024)"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Matharu B, Spencer N, Howe F, Austen B. Gadolinium-complexed A\u03b2-binding contrast agents for MRI diagnosis of Alzheimer\u2019s Disease. Neuropeptides 2015; 53:63\u201370.","DOI":"10.1016\/j.npep.2015.07.001"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Zhang Y, Chen H, Li R, Sterling K, Song W. Amyloid \u03b2-based therapy for Alzheimer\u2019s disease: Challenges, successes and future. Signal Transduct Target Ther 2023; 8:248.","DOI":"10.1038\/s41392-023-01484-7"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. van Dyck CH, Swanson CJ, Aisen P, et al. Lecanemab in early Alzheimer\u2019s disease. N Engl J Med 2023; 388:9\u201321.","DOI":"10.1056\/NEJMoa2212948"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Ma D, Gulani V, Seiberlich N, et al. Magnetic resonance fingerprinting. Nature 2013; 495:187\u2013192.","DOI":"10.1038\/nature11971"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Bipin Mehta B Coppo S, Frances McGivney D, et al. Magnetic resonance fingerprinting: A technical review. Magn Reson Med 2019; 81:25\u201346.","DOI":"10.1002\/mrm.27403"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Zhang Y, Li X, Ji Y, et al. MRA\u03b2: A multimodal MRI-derived amyloid-\u03b2 biomarker for Alzheimer\u2019s disease. Hum Brain Mapp 2023; 44:5139\u20135152.","DOI":"10.1002\/hbm.26452"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Cole E, Cheng J, Pauly J, Vasanawala S. Analysis of deep complex-valued convolutional neural networks for MRI reconstruction and phase-focused applications. Magn Reson Med 2021; 86:1093\u20131109.","DOI":"10.1002\/mrm.28733"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Hirose A. Complex-valued neural networks: Advances and applications. Hoboken: Wiley, 2013; p. 131.","DOI":"10.1002\/9781118590072"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Jiang Y, Ma D, Seiberlich N, Gulani V, Griswold MA. MR fingerprinting using fast imaging with steady state precession (FISP) with spiral readout. Magn Reson Med 2015; 74:1621\u20131631.","DOI":"10.1002\/mrm.25559"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. K\u00f6rzd\u00f6rfer G, Kirsch R, Liu K, et al. Reproducibility and repeatability of MR fingerprinting relaxometry in the human brain. Radiology 2019; 292:429\u2013437.","DOI":"10.1148\/radiol.2019182360"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27. Chung S, Kim D, Breton E, Axel L. Rapid B1+ mapping using a preconditioning RF pulse with TurboFLASH readout. Magn Reson Med 2010; 64:439\u2013446.","DOI":"10.1002\/mrm.22423"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28. Fonov VS, Evans AC, McKinstry RC, Almli CR, Collins DL. Unbiased nonlinear average age-appropriate brain templates from birth to adulthood. Neuroimage 2009; 47:S102.","DOI":"10.1016\/S1053-8119(09)70884-5"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29. Rolls ET, Huang CC, Lin CP, Feng J, Joliot M. Automated anatomical labelling atlas 3. Neuroimage 2020; 206:116189.","DOI":"10.1016\/j.neuroimage.2019.116189"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30. Folstein MF, Folstein SE, McHugh PR. \u201cMini-mental state\u201d: A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975; 12:189\u2013198.","DOI":"10.1016\/0022-3956(75)90026-6"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31. Fujiwara Y, Suzuki H, Yasunaga M, et al. Brief screening tool for mild cognitive impairment in older Japanese: Validation of the Japanese version of the Montreal Cognitive Assessment. Geriatr Gerontol Int 2010; 10:225\u2013232.","DOI":"10.1111\/j.1447-0594.2010.00585.x"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32. Nasreddine ZS, Phillips NA, B\u00e9dirian V, et al. The Montreal Cognitive Assessment, MoCA: A brief screening tool for mild cognitive impairment. J Am Geriatr Soc 2005; 53:695\u2013699.","DOI":"10.1111\/j.1532-5415.2005.53221.x"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33. Tan H, Meyer CH. Estimation of k-space trajectories in spiral MRI. Magn Reson Med 2009; 61:1396\u20131404.","DOI":"10.1002\/mrm.21813"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34. Joshi AD, Pontecorvo MJ, Clark CM, et al. Performance characteristics of amyloid PET with florbetapir F 18 in patients with Alzheimer\u2019s disease and cognitively normal subjects. J Nucl Med 2012; 53:378\u2013384.","DOI":"10.2967\/jnumed.111.090340"},{"key":"35","doi-asserted-by":"crossref","unstructured":"35. Clark CM, Pontecorvo MJ, Beach TG, et al. Cerebral PET with florbetapir compared with neuropathology at autopsy for detection of neuritic amyloid-\u03b2 plaques: A prospective cohort study. Lancet Neurol 2012; 11:669\u2013678.","DOI":"10.1016\/S1474-4422(12)70142-4"},{"key":"36","doi-asserted-by":"crossref","unstructured":"36. Nelissen N, Van Laere K, Thurfjell L, et al. Phase 1 study of the Pittsburgh compound B derivative 18F-flutemetamol in healthy volunteers and patients with probable Alzheimer disease. J Nucl Med 2009; 50:1251\u20131259.","DOI":"10.2967\/jnumed.109.063305"},{"key":"37","doi-asserted-by":"crossref","unstructured":"37. Vandenberghe R, Van Laere K, Ivanoiu A, et al. 18F-flutemetamol amyloid imaging in Alzheimer disease and mild cognitive impairment: A phase 2 trial. Ann Neurol 2010; 68:319\u2013329.","DOI":"10.1002\/ana.22068"},{"key":"38","unstructured":"38. Ronneberger O, Fischer P, Brox T. U-Net: convolutional networks for biomedical image segmentation. arXiv:1505.04597 [cs.CV]."},{"key":"39","unstructured":"39. Zhuang J, Tang T, Ding Y, et al. AdaBelief optimizer: Adapting stepsizes by the belief in observed gradients arXiv:2010.07468 [cs.LG]."},{"key":"40","doi-asserted-by":"crossref","unstructured":"40. Klunk WE, Koeppe RA, Price JC, et al. The centiloid project: Standardizing quantitative amyloid plaque estimation by PET. Alzheimers Dement 2015; 11:1-15.e4.","DOI":"10.1016\/j.jalz.2014.07.003"},{"key":"41","doi-asserted-by":"crossref","unstructured":"41. Ashburner J. A fast diffeomorphic image registration algorithm. Neuroimage 2007; 38:95\u2013113.","DOI":"10.1016\/j.neuroimage.2007.07.007"},{"key":"42","doi-asserted-by":"crossref","unstructured":"42. Bullich S, Ro\u00e9-Vellv\u00e9 N, Marqui\u00e9 M, et al. Early detection of amyloid load using 18F-florbetaben PET. Alzheimers Res Ther 2021; 13:67.","DOI":"10.1186\/s13195-021-00807-6"},{"key":"43","doi-asserted-by":"crossref","unstructured":"43. Raunig DL, McShane LM, Pennello G, et al. Quantitative imaging biomarkers: A review of statistical methods for technical performance assessment. Stat Methods Med Res 2015; 24:27\u201367.","DOI":"10.1177\/0962280214537344"},{"key":"44","unstructured":"44. The R Project for Statistical Computing. https:\/\/www.R-project.org\/ (Accessed December 31, 2024)"},{"key":"45","doi-asserted-by":"crossref","unstructured":"45. Sperling RA, Jack CR Jr., Black SE, et al. Amyloid-related imaging abnormalities in amyloid-modifying therapeutic trials: Recommendations from the Alzheimer\u2019s Association Research Roundtable Workgroup. Alzheimers Dement 2011; 7:367\u2013385.","DOI":"10.1016\/j.jalz.2011.05.2351"},{"key":"46","doi-asserted-by":"crossref","unstructured":"46. Leuzy A, Cullen NC, Mattsson-Carlgren N, Hansson O. Current advances in plasma and cerebrospinal fluid biomarkers in Alzheimer\u2019s disease. Curr Opin Neurol 2021; 34:266\u2013274.","DOI":"10.1097\/WCO.0000000000000904"},{"key":"47","doi-asserted-by":"crossref","unstructured":"47. Graff-Radford J, Yong KXX, Apostolova LG, et al. New insights into atypical Alzheimer\u2019s disease in the era of biomarkers. Lancet Neurol 2021; 20:222\u2013234.","DOI":"10.1016\/S1474-4422(20)30440-3"},{"key":"48","unstructured":"48. Willis DR, Summanwar D, Brosch JR. Blood biomarkers and early detection of Alzheimer\u2019s disease and related dementias. Fam Pract Manag 2025; 32:17\u201320."},{"key":"49","doi-asserted-by":"crossref","unstructured":"49. Palmqvist S, Whitson HE, Allen LA, et al. Alzheimer\u2019s Association Clinical Practice Guideline on the use of blood-based biomarkers in the diagnostic workup of suspected Alzheimer\u2019s disease within specialized care settings. Alzheimers Dement 2025; 21:e70535.","DOI":"10.1002\/alz.70535"},{"key":"50","doi-asserted-by":"crossref","unstructured":"50. Jo M, Lee S, Jeon YM, Kim S, Kwon Y, Kim HJ. The role of TDP-43 propagation in neurodegenerative diseases: Integrating insights from clinical and experimental studies. Exp Mol Med 2020; 52:1652\u20131662.","DOI":"10.1038\/s12276-020-00513-7"},{"key":"51","doi-asserted-by":"crossref","unstructured":"51. Telling ND, Everett J, Collingwood JF, et al. Iron biochemistry is correlated with amyloid plaque morphology in an established mouse model of Alzheimer\u2019s disease. Cell Chem Biol 2017; 24:1205\u20131215.e3.","DOI":"10.1016\/j.chembiol.2017.07.014"}],"container-title":["Magnetic Resonance in Medical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/mrms\/25\/4\/25_mp.2026-0112\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,22]],"date-time":"2026-08-22T05:05:27Z","timestamp":1787375127000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/mrms\/25\/4\/25_mp.2026-0112\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"references-count":51,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.2463\/mrms.mp.2026-0112","relation":{},"ISSN":["1347-3182","1880-2206"],"issn-type":[{"value":"1347-3182","type":"print"},{"value":"1880-2206","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026]]},"article-number":"mp.2026-0112"}}